(Stand Up To Cancer) A new $8 million SU2C Dream Team is focused on therapies for T-cell lymphoma using CARs to trigger the immune system to attack and destroy cancerous cells led by Helen Heslop, M.D., Baylor College of Medicine, co-led by Gianpietro Dotti, M.D., UNC Chapel Hill: seeking to develop "off the shelf" CAR cells improving availability & lowering cost; identifying biomarkers to track therapy effectiveness; evaluating a novel small molecule which shows potential as a cytoreductive regimen.
from EurekAlert! - Social and Behavioral Science http://bit.ly/2DEqemT
No comments:
Post a Comment